The United States regulates the import of all cosmetics, including over-the-counter (OTC) drug products. The agency responsible for enforcing the various requirements is the US Food and Drug Administration (US FDA). The United States recently enacted the Modernization of Cosmetic Regulations Act of 2022 (MoCRA), which significantly expands the regulatory authority of the U.S. Food and Drug Administration (FDA) over the cosmetics industry. MoCRA came into effect on 1st July 2024.

This seminar will offer a comprehensive overview of MoCRA and deep dive into strategies necessary for compliance and success. The speaker will also discuss critical changes unfolding within the cosmetic industry and shed light on the far-reaching impact of the new MoCRA regulations for Cosmetics exports.

Throughout the seminar you will have the opportunity to hear from an industry expert from Registrar Corp who will guide you through the latest developments and help you to understand the implications of MoCRA for exports to the United States.

This seminar will cover a wide range of essential topics, including:

A detailed exploration of MoCRA’s requirements for cosmetics, allowing you to navigate the specific obligations imposed by the new regulations.

In-depth discussions on cosmetics labeling, adverse events, and Good Manufacturing Practices (GMPs) regulations, enabling you to implement compliant practices and ensure product quality.

Best practices for compliance, providing practical guidance to ensure adherence to the latest FDA guidelines and maximize your business’s regulatory compliance efforts

Export Opportunities to the USA under Trump 2.0